Vivos Therapeutics (VVOS) EBIT Margin (2020 - 2026)
Vivos Therapeutics' (VVOS) quarterly EBIT Margin came in at 93.63% in Q2 2026, up 3372.0% year-over-year from 2.7% in Q2 2025, and up 27.23% quarter-over-quarter from 128.67% in Q1 2026.
Powered by 
Analysis
Vivos Therapeutics (VVOS) EBIT Margin (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported EBIT Margin for 7 consecutive years, with 93.63% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBIT Margin rose 3372.0% year-over-year to 93.63% in Q2 2026; TTM through Jun 2026 was 107.92%, a 903.0% decrease from a year earlier, with the FY2025 full-year figure at 114.05%, down 3973.0% from the prior year.
- EBIT Margin was 93.63% for Q2 2026 at Vivos Therapeutics, up from 128.67% in the prior quarter.
- Over five years, EBIT Margin peaked at 47.76% in Q2 2024 and troughed at 182.19% in Q1 2022.
- A 5-year average of 119.38% and a median of 127.35% in 2025 frame the typical range for EBIT Margin.
- Across the five-year window, EBIT Margin jumped 8529 bps in 2024 and slumped 9101 bps in 2025, its largest moves.
- Over 5 years, EBIT Margin stood at 153.49% in 2022, then rose by 17 bps to 127.25% in 2023, then soared by 40 bps to 75.88% in 2024, then slumped by 120 bps to 166.89% in 2025, then soared by 44 bps to 93.63% in 2026.
- The last three EBIT Margin figures came in at 93.63% (Q2 2026), 128.67% (Q1 2026), and 166.89% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 10.72 Bn | 9.62 Bn | 757.43 Mn | 14.58% |
| 2 | Envista Holdings | 4.23 Bn | 3.10 Bn | 407.00 Mn | 10.99% |
| 3 | Dentsply Sirona | 2.11 Bn | 1.87 Bn | 493.00 Mn | 9.13% |
| 4 | Milestone Scientific | 35.01 Mn | 32.40 Mn | 1.56 Mn | -38.30% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 3.19 Mn | 1.39 Mn | 2.95 Mn | -93.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -93.63% |
| Mar 31, 2026 | -128.67% |
| Dec 31, 2025 | -166.89% |
| Sep 30, 2025 | -69.79% |
| Jun 30, 2025 | -127.36% |
| Mar 31, 2025 | -129.91% |
| Dec 31, 2024 | -75.88% |
| Sep 30, 2024 | -68.52% |
| Jun 30, 2024 | -47.76% |
| Mar 31, 2024 | -110.70% |
| Dec 31, 2023 | -127.25% |
| Sep 30, 2023 | -110.27% |
| Jun 30, 2023 | -133.05% |
| Mar 31, 2023 | -129.76% |
| Dec 31, 2022 | -153.49% |
| Sep 30, 2022 | -127.34% |
| Jun 30, 2022 | -166.44% |
| Mar 31, 2022 | -182.19% |
| Dec 31, 2021 | -168.66% |
| Sep 30, 2021 | -121.05% |